Studies to verify correlations between phenotypes and genotypes of herpes simplex virus (HSV) are an important tool to establish a database of resistance-associated mutations.
Methods
In this study, 32 acyclovir (ACV)-resistant clinical HSV-1 and 4 ACV-resistant clinical HSV-2 isolates were examined in parallel by both phenotypic and genotypic resistance testing. Additionally, five non-viable HSV-1 strains and two non-viable HSV-2 strains with clinical resistance were included in genotypic resistance analysis.
Results
All ACV-resistant HSV isolates showed cross-resistance to brivudin and penciclovir, and were sensitive to foscarnet and cidofovir. Acyclovir resistance was assigned to frameshift and single non-synonymous mutations of the thymidine kinase (TK) gene in 32 out of 37 HSV-1 strains and in 4 out of 6 HSV-2 strains. In three HSV-1 isolates, there were resistance-associated amino acid substitutions of the DNA polymerase (pol). Six substitutions in the TK and two in the DNA pol gene could not be attributed without doubt to either ACV resistance or natural gene polymorphism. Altogether, 10 resistance-related mutations in the TK and 1 in the DNA pol gene have not been reported previously.
Conclusions
The novel non-synonymous mutations found in this study enrich the knowledge about the genetic alterations of TK and DNA pol genes in ACV-resistant clinical HSV strains. Together with data from the literature, the findings justify the generation of a HSV database that contains resistance mutations associated with ACV resistance phenotype.
References
1.
StanberryL.R., Floyd-ReisingS.A., ConnellyB.L.Herpes simplex viremia: report of eight pediatric cases and review of the literature. Clin Infect Dis1994; 18: 401–407.
2.
RamseyP.G., FifeK.H., HackmanR.C., MeyersJ.D., CoreyL.Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med1982; 97: 813–820.
3.
JohnsonJ.R., EgaasS., GleavesC.A., HackmanR., BowdenR.A.Hepatitis due to herpes simplex virus in marrow-transplant recipients. Clin Infect Dis1992; 14: 38–45.
4.
KaufmanB., GandhiS.A., LouieE., RizziR., IlleiP.Herpes simplex virus hepatitis: case report and review. Clin Infect Dis1997; 24: 334–338.
5.
CollinsP., EllisM.N.Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol1993; 41Suppl 1: 58–66.
6.
Danve-SzatanekC., AymardM., ThouvenotD.Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol2004; 42: 242–249.
7.
EnglundJ.A., ZimmermannM.E., SwierkoszE.M., GoodmanJ.L., SchollD.R., BalfourH.H.Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med1990; 112: 416–422.
8.
IllánH., JacobN., MaioloE., CisternaD., SchiavelliR., FreireM.C.Antiviral sensitivity of herpes simplex virus in immunocompromised patients. Rev Argent Microbiol2004; 36: 88–91.
9.
ChakrabartiS., PillayD., RatcliffeD., CaneP.A., CollinghamK.E., MilliganD.W.Resistance to antiviral drugs in herpes simplex virus infections among allogenic stem cell transplant recipients: risk factors and prognostic significance. J Infect Dis2000; 181: 2055–2058.
10.
Bestman-SmithJ., SchmittI., PapadopoulouB., BoivinG.Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. J Virol2001; 75: 3105–3110.
LarderB.A., DarbyG.Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology1985; 146: 262–271.
13.
SafrinS., AsseykeenT., FollansbeeS., MillsJ.Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. J Infect Dis1990; 161: 1078–1084.
14.
TanH.H., GohC.L.Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol2006; 7: 13–29.
15.
WylesD.L., PatelA., MadingerN., BessesenM., KrauseP.R., WeinbergA.Development of herpes simplex virus disease in patients who are receiving cidofovir. Clin Infect Dis2005; 41: 676–680.
BalfourH.H.Jr., BensonC., BraunJ.Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr1994; 7: 254–260.
18.
SauerbreiA., DeinhardtS., ZellR., WutzlerP.Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus. Antiviral Res2010; 86: 246–252.
19.
SafrinS., CrumpackerC., ChatisP.A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med1991; 325: 551–555.
20.
McGeochD.J., DolanA., DonaldS., RixonF.J.Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol1985; 181: 1–13.
21.
McGeochD.J., MossH.W., McNabD., FrameM.C.DNA sequence and genetic content of the Hind III 1 region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparison. J Gen Virol1987; 68: 19–38.
22.
SuzutaniT., IshiokaK., De ClercqE.Differential mutation pattern in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir. Antimicrob Agents Chemother2003; 47: 1707–1713.
23.
BohnK., ZellR., SchackeM., WutzlerP., SauerbreiA.Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus. Antivir Ther doi: 10.3851/IMP1852.
24.
FyfeJ.A.Differential phosphorylation of (E)-5(2-bromovinyl)-2′-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella-zoster virus. Mol Pharmacol1982; 21: 432–437.
25.
SariskyR.T., QuailM.R., ClarkP.E.Characterization of herpes simplex viruses selected in culture for resistance to penciclovir and acyclovir. J Virol2001; 75: 1761–1769.
GaudreauA., HillE., BalfourH.H.Jr., EriceA., BoivinG.Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis1998; 178: 297–303.
28.
FrobertE., CortayJ.C., OokaT.Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res2008; 79: 28–36.
29.
ChiboD., DruceJ., SasadeuszJ., BirchC.Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antiviral Res2004; 61: 83–91.
30.
MorfinF., SouilletG., BilgerK., OokaT., AymardM., ThouvenotD.Genetic characterization of thymindine kinase from acyclovir-resistant and –susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J Infect Dis2000; 182: 290–293.
31.
SaijoM., SuzutaniT., De ClercqE.Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain. Antiviral Res2002; 56: 253–262.
32.
BaeP.K., KimJ.H., KimH.S., ChungI.K., PaikS.G., LeeC.K.Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1. Antiviral Res2006; 70: 93–104.
33.
GilbertC., Bestman-SmithJ., BoivinG.Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat2002; 5: 88–114.
34.
LarderB.A., KempS.D., DarbyG.Related functional domains in virus DNA polymerases. EMBO J1987; 6: 169–175.
35.
BurrelS., DebackC., AgutH., BoutolleauD.Genotypic characterization of UL23 thymindine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother2010; 54: 4833–4842.
36.
StránskáR., SchuurmanR., NienhuisE.Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol2005; 32: 7–18.
37.
DuanR., de VriesR.D., van DunJ.M.Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis2009; 200: 1402–1414.
38.
ChevillotteM., von EinemJ., MeierB.M., LinF.M., KestlerH.A., MertensT.A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes. Antiviral Res2010; 85: 318–327.
